Table 2.
Simulation and calculation results under the exposure of non-antibiotic pharmaceuticals.
Condition | Kμ* | Amplify factor of Kμ* | μ | Kd* | Amplify factor of Kd* | d | Stability time (h)a |
---|---|---|---|---|---|---|---|
Control | 0.157 | 1 | 1.75 × 10−9 | 0.936 | 1 | 0.0117 | 178 |
Ibuprofen | 0.856 | 5.5 | 9.54 × 10−9 | 1.109 | 1.1848 | 0.0139 | 148 |
Naproxen | 1.230 | 7.8 | 1.37 × 10−8 | 0.946 | 1.0107 | 0.0118 | 153 |
Gemfibrozil | 2.937 | 18.7 | 3.27 × 10−8 | 0.955 | 1.0203 | 0.0119 | 152 |
Diclofenac | 1.576 | 10.0 | 1.76 × 10−8 | 1.161 | 1.2404 | 0.0145 | 134 |
Propranolol | 2.984 | 19.0 | 3.33 × 10−8 | 1.193 | 1.2746 | 0.0149 | 131 |
Iopromide | 0.395 | 2.5 | 4.41 × 10−9 | 0.969 | 1.0353 | 0.0121 | 171 |
Combined effect | – | – | – | Product | 1.9998 | 0.0233 | 105 |
aThe time reaching 95% of the final theoretical value.